N.J. High Court Creates Formal Docket for Centralized Management of Olmesartan Medoxomil Litigation

TRENTON, N.J. — The New Jersey Supreme Court has granted a request by the makers of blood pressure drugs containing olmesartan medoxomil to create a formal docket for the centralized management of products liability cases in which they have been named as defendants.

According to an Aug. 31 notice to the bar, the court appointed Judge Nelson C. Johnson Inc. of the Atlantic County (N.J.) Superior Court to oversee the docket.

“All pending and future New Jersey state court actions alleging spruelike enteropathy and/or lymphocytic colitis, microscopic colitis or collagenous colitis and other symptoms as a result of treatment with …